A novel measure to summarize blood transfusion practice during critical illness
Transfusion · 2024
DOI: 10.1111/trf.17814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Nicholas A Bosch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Allergy, Sleep & Critical Care Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Bo…. Hauptthemen laut MEDLINE: Critical Illness, Hemoglobins, Erythrocyte Transfusion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Large‐scale observational studies have summarized transfusion practice using traditional measures of central tendency (e.g., the mean hemoglobin concentration at the time of transfusion). However, the mean hemoglobin concentration fails to identify specific hemoglobin concentration thresholds that drive practice. In the following brief report, we propose a novel measure of “practice discontinuity” that identifies specific practice‐defining hemoglobin thresholds. Study Design and Methods We used the PINC AI Database (2016–2022) to identify adult patients admitted to an intensive care unit with at least one hemoglobin concentration measurement. For each day that hemoglobin was measured, we identified whether the patient received a red blood cell transfusion using hospital charge codes. We defined the “practice discontinuity” measure as the hemoglobin concentration at which there was the largest increase in transfusion use going from a higher to an incrementally lower hemoglobin concentration. We also calculated the mean and median pretransfusion hemoglobin concentrations.
Results
We identified 1,298,367 patients and 4,905,839 patient‐days for inclusion. RBC transfusion occurred in a total of 530,654 (10.8%) patient‐days. The overall pre‐transfusion mean and median hemoglobin concentrations were 8.4 and 8.0 g/dL, respectively. The practice discontinuity measure identified 7.0 g/dL as the hemoglobin concentration at which transfusion use increased the most, from 46.6% of patient‐days at a concentration of 7.0 g/dL to 74.8% of patient‐days at a concentration of 6.9 g/dL.
Discussion
We propose that future studies of red blood cell transfusion practice consider inclusion of the practice discontinuity measure to more fully summarize clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pulmonary, Allergy, Sleep & Critical Care Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
- Section of Rheumatology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
- Division of Health Systems Science, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.
ORCID-Profile: Nicholas A Bosch, Zhan Shi, S Reza Jafarzadeh
Förderung
- NCATS NIH HHS
- NHLBI NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Bosch, N. A., Law, A. C., Shi, Z., Jafarzadeh, S. R., & Walkey, A. J. (2024). A novel measure to summarize blood transfusion practice during critical illness. Transfusion. https://doi.org/10.1111/trf.17814
Vancouver
Bosch NA, Law AC, Shi Z, Jafarzadeh SR, Walkey AJ. A novel measure to summarize blood transfusion practice during critical illness. Transfusion. 2024. doi:10.1111/trf.17814
BibTeX
@article{Bosch2024,
author = {Bosch, Nicholas A and Law, Anica C and Shi, Zhan and Jafarzadeh, S Reza and Walkey, Allan J},
title = {A novel measure to summarize blood transfusion practice during critical illness},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17814}
}
EUVIMED